Methylprednisolone Hemisuccinate: Clinical Trials

188 trials of Methylprednisolone Hemisuccinate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

100 completed, 27 unknown, 26 terminated, 15 recruiting. 83 Phase 2, 47 Phase 3, 36 Phase 4, 26 Phase 1, 17 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 283Completed 42, Terminated 16, Unknown 10, Recruiting 5, Withdrawn 4, Active not recruiting 3, Not yet recruiting 3
Phase 347Completed 22, Unknown 10, Terminated 7, Recruiting 3, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1
Phase 436Completed 20, Recruiting 5, Unknown 5, Terminated 3, Not yet recruiting 2, Enrolling by invitation 1
Phase 126Completed 12, Unknown 5, Terminated 4, Recruiting 2, Withdrawn 2, Not yet recruiting 1
Not applicable17Completed 12, Withdrawn 2, Not yet recruiting 1, Terminated 1, Unknown 1
Early Phase 15Completed 2, Unknown 2, Recruiting 1

Follow this drug Literature Review of Methylprednisolone Hemisuccinate trials Research Report on Methylprednisolone Hemisuccinate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritis
High-dose PCP-PBMCs injection, Solu-Medrol, Low-dose PCP-PBMCs injection - Knee Osteoarthritis
Phase 2 / Phase 3Not yet recruitingDuoGenic StemCells Corporation (DGSC)2402026-09-302026-07-20
Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic Neuropathy
Teprotumumab N01, Intravenous Methylprednisolone (IVMP) - Thyroid Eye Disease, TED, Graves Ophthalmopathy
Phase 2Not yet recruitingSun Yat-sen University602026-08-012026-05-19
IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage
Lidocaine hydrochloride, Methylprednisolone sodium succinate - Headaches Associated With Subarachnoid Hemorrhage (SAH)
Phase 2RecruitingDaniel Raper, MBBS252026-06-232026-07-08
Evaluation of Corticosteroid Administration Following Impacted Third Molar Surgery Using 3-Dimensional Facial Analysis
Surgical Extraction of Impacted Mandibular Third Molar, methylprednisolone sodium succinate, Dexamethasone Sodium Phosphate Injection - Impacted Mandibular Third Molar Extraction, Postoperative Pain Control
Not applicableCompletedIrfan Üstündağ602026-03-022026-06-04
Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia
Methylprednisolone - Acute Respiratory Failure, Community-Acquired Pneumonia
Phase 1 / Phase 2Not yet recruitingQingyuan Zhan5002026-02-012026-01-22
Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis
Oral Upadacitinib, Intravenous Methylprednisolone, Oral Upadacitinib Placebo - Ulcerative Colitis Acute
Phase 4RecruitingBerinstein, Jeffrey1102026-01-162026-02-02
Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease
Gecacitinib-Corticosteroid, Methylprednisolone sodium succinate - aGVHD
Phase 2RecruitingBin Gu252026-01-012026-09-23
Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke
Methylprednisolone sodium succinate, Placebo - Ischemic Stroke, Acute
Not applicableNot yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University9122025-10-012025-09-16
A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG
Normal saline, Dexmedetomidine, Methylprednisolone - Coronary Artery Disease, Systemic Inflammatory Response Syndrome
Phase 1 / Phase 2UnknownAin Shams University602025-09-012025-08-06
Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia
Methylprednisolone sodium succinate, Normal Saline - Large Infarct Core, Post-stroke Lymphocytopenia
Phase 3RecruitingYiLin2002025-09-012025-10-01
MAGIC Ruxolitinib for aGVHD
Ruxolitinib, Methylprednisolone - Acute Graft-versus-host Disease, Allogeneic Bone Marrow Transplantation
Phase 2RecruitingJohn Levine982025-05-142026-03-23
Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage
Simple neuroendoscopic hematoma evacuation, Neuroendoscopic hematoma evacuation combined with sodium methylprednisolone succinate - Stroke, Intracerebral Hemorrhage Basal Ganglia
Phase 4Not yet recruitingYong Jiang1002025-05-012025-04-13
Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Lobar Intracerebral Hemorrhage at the Early Stage.
Simple neuroendoscopic hematoma evacuation, Neuroendoscopic hematoma evacuation combined with sodium methylprednisolone succinate - Stroke, Intracerebral Hemorrhage Lobar
Phase 4Not yet recruitingYong Jiang3962025-05-012025-04-13
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
Methylprednisolone sodium succinate, Placebo - Acute Ischemic Stroke, Large Infarct Core
Phase 3Active not recruitingWan-Jin Chen9282024-08-012025-12-03
Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications
Methyl Prednisolone (MP), Hyaluronic Acid (HA) - Wisdom Tooth Removal, Post Operative Complications
Phase 3Enrolling by invitationSana'a University402024-06-272026-04-30
MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)
Methylprednisolone 125 MG, IV saline solution 0.9% - Acute Myocarditis
Phase 3RecruitingUniversity Hospital, Antwerp1742024-05-242025-04-17
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
Solumedrol - Refractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active)
Phase 3UnknownSohag University2152024-05-012024-06-17
Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Solumedrol - Active Rheumatoid Arthritis
Phase 3UnknownSohag University2682024-05-012024-06-13
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
Dexamethasone, Methylprednisolone, 2% Lidocaine HCl Injection - Sacroiliac Joint Dysfunction, Sacro-Iliac Spondylosis
Phase 4RecruitingUniversity of New Mexico2302024-03-272025-11-06
Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1
Lidocaine hydrochloride, Methylprednisolone sodium succinate - Refractory Migraine
Phase 1CompletedThe Cooper Health System102024-03-152025-11-04

Showing 20 of 188. Sign in to see all of them.

Conditions studied

Leukemia (12)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (12)  ·  Leukemia, Myeloid, Acute (9)  ·  Osteoarthritis (8)  ·  COVID-19 (7)  ·  Lymphoma (7)  ·  Lymphoma, Non-Hodgkin (7)  ·  Burkitt Lymphoma (6)  ·  Graft vs Host Disease (6)  ·  Lymphoma, Follicular (6)  ·  Lymphoma, Large B-Cell, Diffuse (6)  ·  Myelodysplastic Syndromes (6)  ·  Blast Crisis (5)  ·  Graves Ophthalmopathy (5)  ·  Lymphoma, Mantle-Cell (5)

Sponsors

M.D. Anderson Cancer Center (11)  ·  Copenhagen University Hospital, Rigshospitalet (7)  ·  Stanford University (7)  ·  Northwestern University (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Children's Oncology Group (3)  ·  National Taiwan University Hospital (3)  ·  Washington University School of Medicine (3)  ·  A. Manzoni Hospital (2)  ·  Ain Shams University (2)  ·  Assiut University (2)  ·  Berinstein, Jeffrey (2)  ·  Case Comprehensive Cancer Center (2)  ·  Cedars-Sinai Medical Center (2)  ·  Emory University (2)

Countries

United States (88)  ·  Denmark (19)  ·  China (14)  ·  Italy (10)  ·  Canada (9)  ·  Belgium (8)  ·  Egypt (8)  ·  France (6)  ·  Taiwan (6)  ·  Germany (5)  ·  Switzerland (5)  ·  Netherlands (4)  ·  Sweden (4)  ·  United Kingdom (4)  ·  Austria (3)

Top investigators

Richard Burt, MD (6)  ·  Viktoria Lindberg-Larsen, MD (6)  ·  Wen-Kai Weng (3)  ·  Jeffrey Berinstein, MD, MSc (2)  ·  Robert Lowsky (2)  ·  Rodica Morariu-Zamfir, MD (2)  ·  Sergio Giralt, MD (2)  ·  Alaa F Fathy, researcher (1)  ·  Alexandra L Goodyear, MD, MS (1)  ·  Amal Y Al-Eryani (1)  ·  Amin Alousi, MD (1)  ·  Antonello Pani, MD (1)  ·  Arnaldo P Barbosa (1)

Results publications

PMID 11919310, PMID 12359731, PMID 14667752, PMID 15851648, PMID 17452226, PMID 17533019, PMID 17978307, PMID 19005182, PMID 19571790, PMID 19571791, PMID 20148887, PMID 20671616, PMID 21044725, PMID 21606384, PMID 21610239, PMID 21852672, PMID 22174345, PMID 22438229, PMID 22563089, PMID 22797672, PMID 22805100, PMID 23361904, PMID 23369458, PMID 23587468, PMID 23774314, PMID 23870160, PMID 24029421, PMID 24674813, PMID 25018935, PMID 25058803, PMID 25058804, PMID 25115430, PMID 25253674, PMID 25343233, PMID 25505035, PMID 25585823, PMID 25791027, PMID 26231455, PMID 26446165, PMID 26477577, PMID 26630142, PMID 2665875, PMID 26688484, PMID 27287853, PMID 27403440, PMID 27477797, PMID 28341274, PMID 28422025, PMID 28609319, PMID 28627134

NIH funding

P30CA016672 (4), 2015 (3), 2017 (2), U10CA098543 (2), 2005 (1), 2009 (1), 2014 (1), 2018 (1), K23DK134764 (1), P01CA018029 (1), P01CA039542 (1), P01CA049605 (1), P30CA012197 (1), P30CA023074 (1), P30CA036727 (1)